CARLSBAD, Calif., February 05, 2025--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Wednesday, February 19 th at 11:30 a.m. Eastern ...
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core ...
Furthermore, Ionis is preparing for the launch of donidalorsen for hereditary angioedema and is engaged in a partnership with AstraZeneca for the launch of Wainua in the U.S. and expected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback